Ile178 of HIV-1 reverse transcriptase is critical for inhibiting the viral integrase

Iris Oz Gleenberg, Yehuda Goldgur, Amnon Hizi*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

HIV-1 reverse transcriptase (RT) was shown to inhibit in vitro the viral integrase (IN). We have reported previously that an RT-derived 20-residue peptide binds IN and inhibits its enzymatic activities. In this peptide, Leu168, Phe171, Gln174, and Ile178 were predicted to be involved in IN inhibition. In the presented study, these residues were mutagenized and the resulting peptides were tested for binding and inhibiting IN activities. Ile178 was found to be the major contributor to IN inhibition, probably by interacting with IN residue Gly149. As Gly149 is a key IN residue, this inhibition probably results from a steric hindrance of the IN active site.

Original languageEnglish
Pages (from-to)48-52
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume364
Issue number1
DOIs
StatePublished - 7 Dec 2007

Funding

FundersFunder number
Israeli Science Foundation405/02

    Keywords

    • HIV-1
    • Inhibition
    • Integrase
    • Mutation
    • Peptides
    • Reverse transcriptase

    Fingerprint

    Dive into the research topics of 'Ile178 of HIV-1 reverse transcriptase is critical for inhibiting the viral integrase'. Together they form a unique fingerprint.

    Cite this